Luz María Gonzalez Huerta

Dr. Luz María Gonzalez Huerta

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
MMM. Martínez-Saucedo
M. Martínez-Saucedo
MRM.R. Rivera-Vega
M.R. Rivera-Vega
LHLuz María Gonzalez Huerta
Luz María Gonzalez Huerta
HUH. Urueta-Cuellar
H. Urueta-Cuellar
JLJaime Toral López
Jaime Toral López
SCSergio Cuevas-Covarrubias,
Sergio Cuevas-Covarrubias,

19 January 2009 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
LHLuz María Gonzalez Huerta
Luz María Gonzalez Huerta
JMJaime Mendiola‐Jimenez
Jaime Mendiola‐Jimenez
MMMaria Del Moral‐Stevenel
Maria Del Moral‐Stevenel
MRMaria Rivera‐Vega
Maria Rivera‐Vega
SCSergio Alberto Cuevas Covarrubias
Sergio Alberto Cuevas Covarrubias

8 March 2024 in Biology
Verified
Journal Article
Open access
PDF file
JLJaime Toral López
Jaime Toral López
SGSandra Araceli Gómez-Martínez
Sandra Araceli Gómez-Martínez
MVMaría del Refugio Rivera Vega
María del Refugio Rivera Vega
Edgar Hernández-ZamoraEdgar Hernández-Zamora
Edgar Hernández-Zamora
SCSergio Cuevas-Covarrubias,
Sergio Cuevas-Covarrubias,
LHLuz María Gonzalez Huerta
Luz María Gonzalez Huerta
Cleidocranial dysplasia (CCD) is an autosomal dominant skeletal dysplasia characterized by persistent open skull sutures with bulging calvaria, hypoplasia, or aplasia of clavicles permitting abnormal opposition of the shoulders; wide public symphysis; short middle phalanx of the fifth fingers; and vertebral, craniofacial, and dental anomalies. It is a rare disease, with a prevalence of 1–9/1,000,000, high penetrance, and variable expression. The gene responsible for CCD is the Runt-related transcription factor 2 (RUNX2) gene. We characterize the clinical, genetic, and bioinformatic results of four CCD cases: two cases within Mexican families with six affected members, nine asymptomatic individuals, and two sporadic cases with CCD, with one hundred healthy controls. Genomic DNA analyses of the RUNX2 gene were performed for Sanger sequencing. Bioinformatics tools were used to predict the function, stability, and structural changes of the mutated RUNX2 proteins. Three novel heterozygous mutations (c.651_652delTA; c.538_539delinsCA; c.662T>A) and a previously reported mutation (c.674G>A) were detected. In silico analysis showed that all mutations had functional, stability-related, and structural alterations in the RUNX2 protein. Our results show novel mutations that enrich the pool of RUNX2 gene mutations with CCD. Moreover, the proband 1 presented clinical data not previously reported that could represent an expanded phenotype of severe expression.

11 October 2024 in Diseases
Verified
Journal Article
Open access
PDF file
JLJaime Toral López
Jaime Toral López
CTCesar Candia Tenopala
Cesar Candia Tenopala
DMDaniela Mosqueda
Daniela Mosqueda
MSMiguel Ángel Fonseca Sánchez
Miguel Ángel Fonseca Sánchez
LHLuz María Gonzalez Huerta
Luz María Gonzalez Huerta
Background: Vitamin D-dependent rickets type 1A (VDDR1A) is a rare autosomal recessive disorder caused by pathogenic variants in the CYP27B1 gene, typically characterized by growth failure, rickets, leg bowing, fracture, seizures, hyperparathyroidism, hypocalcemia, high-alkaline phosphatase, high or normal 25(OH)D3, and low 1,25(OH)2D3. Methods: We studied two siblings in a Mexican family with an atypical form of VDDR1A. In addition to the typical features of VDDR1A, the proband showed cafe au lait spots, small teeth, and grayish sclera, with hypophosphatemia, normocalcemia, and normal 25(OH)D3; the proband’s brother showed grayish sclera. The proband underwent next generation sequencing. Sanger sequencing was performed in the proband, his brother, the parents, and 100 healthy controls validate the detected variant. Results: Both brothers presented with a recurrent variant NM_000785.3; c.1319_1325dupCCCACCC and a novel nonsense variant NM_000785.3; c.227G>A in the CYP27B1 gene. Conclusions: Calcitriol treatment had a better response in proband´s younger brother. We describe the first Mexican family with an atypical form of VDDR1A associated with a novel nonsense variant, the results contribute to the phenotypic spectrum and increase the pool of pathogenic variants in CYP27B1. Data suggest that nonsense-truncating variants play a significant role in the severity of VDDR1A.

31 January 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
JLJaime Toral López
Jaime Toral López
SGSandra Araceli Gómez-Martínez
Sandra Araceli Gómez-Martínez
MVMaría de Refugio Rivera Vega
María de Refugio Rivera Vega
SCSergio Cuevas-Covarrubias,
Sergio Cuevas-Covarrubias,
Edgar Hernández-ZamoraEdgar Hernández-Zamora
Edgar Hernández-Zamora
LHLuz María Gonzalez Huerta
Luz María Gonzalez Huerta
Cleidocranial dysplasia (CCD) is an autosomal dominant skeletal dysplasia characterized by persistent open skull sutures whit bulging calvaria, hypoplasia or aplasia of clavicles permitting abnormal opposition of the shoulders, wide public symphysis, short middle phalanx of the fifth fingers and vertebral, craniofacial and dental anomalies. It is a rare disease, with a prevalence of 1-9/1,000,000, high penetrance, and variable expression. The responsible gene of CCD is the runt-related transcription factor 2 gene (RUNX2). We characterize the clinical, genetic and bioinformatic results of four CCD cases. Two Mexican familial with 6 affected members, 9 asymptomatic individuals, and two sporadic cases with CCD, as well as 100 healthy controls. Genomic DNA analyses of the RUNX2 gene was performed for Sanger sequencing. Bioinformatics tools, used to predict the function, stability, and structural changes of the mutated RUNX2 proteins. Three novel heterozygous mutations (c.651_652del; c.538_539delinsCA; c.662T>A) and a previously reported mutation (c.674G>A) were detected. In silico analysis showed that all mutations had functional, stability, and structural alterations in RUNX2 protein. Our results show novel mutations that enrich the pool of RUNX2 gene mutations with CCD. In addition, one patient presented clinical data not previously reported that could represent an expanded phenotype of sever expression.

10 March 2023 in Salud Pública de México
Verified
Journal Article
Open access
PDF file
LHLuz María Gonzalez Huerta
Luz María Gonzalez Huerta
AHAlfonso Hernández-Vázquez
Alfonso Hernández-Vázquez
JLJaime Toral López
Jaime Toral López
MRMaría Del Refugio Rivera-Vega
María Del Refugio Rivera-Vega
MEMario Escobar-Gómez
Mario Escobar-Gómez
Edgar Hernández-ZamoraEdgar Hernández-Zamora
Edgar Hernández-Zamora